BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11933754)

  • 1. [Delayed hypersensitivity to heparins and heparinoids].
    Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
    Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
    Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
    Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A; Fritsch P; Reider N
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C; Aberer W; Kränke B
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.
    Koch P; Reinhold S; Busch C
    Contact Dermatitis; 2000 May; 42(5):278-9. PubMed ID: 10789845
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
    Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
    Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation with recombinant hirudin following bone marrow transplantation in a patient with activated protein C resistance and heparin-induced antibodies showing cross-reactivity to the heparinoid danaparoid.
    Sauer M; Gruhn B; Fuchs D; Altermann WW; Greinacher A; Völpel H; Zintl F
    Med Pediatr Oncol; 1999 Jun; 32(6):457-8. PubMed ID: 10358710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of low molecular weight heparins by dermatologists].
    Maakaroun A; Gruel Y
    Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R; Glässl A; Landthaler M; Stolz W
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
    Taylor AA
    BJOG; 2001 Sep; 108(9):1011-2. PubMed ID: 11563455
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
    Counsell C; Sandercock P
    Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
    Shapiro M; Cohen J; Inbal A; Singer P
    Isr Med Assoc J; 2009 Mar; 11(3):188-90. PubMed ID: 19544713
    [No Abstract]   [Full Text] [Related]  

  • 18. Eczema-like plaques to enoxaparin.
    Valdés F; Vidal C; Fernández-Redondo V; Peteiro C; Toribio J
    Allergy; 1998 Jun; 53(6):625-6. PubMed ID: 9689351
    [No Abstract]   [Full Text] [Related]  

  • 19. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of 19 cases of allergy to heparins with positive skin testing].
    Phan C; Vial-Dupuy A; Autegarden JE; Amsler E; Gaouar H; Abuaf N; Pecquet C; Francès C; Soria A
    Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.